Classes
- ?E0110026A | Faculty of Medicine in Pilsen
- Pulmonary medicineEA0110026 | Faculty of Medicine in Pilsen
- Special Fields of Internal Medicine - pneumologyEA0110026A | Faculty of Medicine in Pilsen
- Possibilities of treatement of pleural disseasesED1P011 | Faculty of Medicine in Pilsen
- Allergies and and airway diseases presented at ERS Annual Congress Amsterdam 2011ED1P101 | Faculty of Medicine in Pilsen
- Parapneumonic fluridothorax, pyothoraxED2P011 | Faculty of Medicine in Pilsen
- Autoimunne Interstitial Lung DiseaseED2P101 | Faculty of Medicine in Pilsen
- HAVEDSZ011 | Faculty of Medicine in Pilsen
- Immunopathology of chronic inflammatory and fibrotic lung and airway diseasesEDSZ101 | Faculty of Medicine in Pilsen
Publications
- First experiences with detecting ALK (anaplastic lymphoma kinase) gene rearrangement and administration of crizotinib in selected patients with non-small cell lung cancer (NSCLC)2012 | Faculty of Medicine in Pilsen
- EGFR mutations in patients with advanced NSCLC2012 | Faculty of Medicine in Pilsen
- First experience on crizotinib therapy in non small cell lung cancer patient with EML-4 ALK translocation in Czech republic2012 | Faculty of Medicine in Pilsen
- Crizotinib as a next molecularly targeted drug in non small cell lung cancer2012 | Faculty of Medicine in Pilsen
- Analysis of advancer NSCLC patients with prolonged progression-free survival after EGFR tyrosine kinase therapy2011 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- The new moleculary targeted drug for the treatment of non small cell lung cancer (NSCLC)2011 | Faculty of Medicine in Pilsen
- Methylation analysis in NSCLC. Frequency of gene-specific hypermethylation depending on the histological type of carcinoma and smoking status2010 | Central Library of Charles University
- Gefitinib2010 | Central Library of Charles University
- Role of single nucleotide polymorphisms in ERCC1, ERCC2, XRCC1 and XRCC3 genes in the prediction of treatment response to chemothersapy in non small cell lung cancer2009 | Central Library of Charles University
- Impact of EGFR and KRAS mutations on survival prognosis of NSCLC patients treated with tyrosine-kinase inhibitors: Comparison of gefitinib and erlotinib.2009 | Central Library of Charles University
Loading network view...